BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• Business

  TiGenix Obtains Commercial Production License For Expanded Manufacturing Facility

  September 5, 2017

   · 

  7 min read
• Drug Development

  Citius Pharma Provides Phase III Update On Mino-Lok Clinical Trial Following FDA Meeting

  September 5, 2017

   · 

  4 min read
• Policy

  Yield10 Bioscience Obtains Confirmation Of Nonregulated Status From USDA-APHIS For Its Genome-Edited Camelina Lin

  September 5, 2017

   · 

  4 min read
• Policy

  Biotricity FDA Submission Update

  September 5, 2017

   · 

  4 min read
• Drug Development

  ProQR Therapeutics’s Drug Candidate QRX-421 For Usher Syndrome Receives Orphan Drug Designation From FDA And EMA

  September 5, 2017

   · 

  5 min read
• Business

  Biocryst Announces Corporate Update Conference Call And Webcast

  September 5, 2017

   · 

  1 min read
• Drug Development

  Biocryst Announces Positive Results From Its Apex-1 Phase II Trial In HAE

  September 5, 2017

   · 

  9 min read
• Policy

  Ortho Dermatologics Submits New Drug Application To The FDA For Psoriasis Treatment IDP-118

  September 5, 2017

   · 

  4 min read
• Potential Device Malfunction Forces Apotex to Recall One Lot of Its Apo-Nitroglycerin Sublingual Spray

  September 5, 2017

   · 

  2 min read
• Enzyvant Sciences Receives FDA Rare Pediatric Disease Designation For Investigational Therapy RVT-802

  September 5, 2017

   · 

  4 min read